Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
Clinical trial NCT00905307 · COMPLETED
Trial details
- NCT number
- NCT00905307
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2010-09-01
- Enrollment
- 459
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.